- Home
- / Guardion Health Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Guardion Health Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.3
2024-10-29
Market Capitalization
$4.4 M
2024-10-29
Revenue
$12.2 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 141.0K | 437.3K | 942.2K | 902.9K | 1.9M | 7.2M | 11.0M | 12.2M |
| Cost of goods sold | 75.7K | 175.5K | 398.2K | 341.3K | 1.9M | 4.1M | 6.5M | 6.9M |
| Gross profit | 65.3K | 261.9K | 544.0K | 561.6K | (56.8K) | 3.1M | 4.5M | 5.4M |
| Gross profit margin, % | 46.3% | 59.9% | 57.7% | 62.2% | -3.0% | 40.9% | 44.0% | |
| General and administrative expense | 3.3M | 4.7M | 4.9M | 7.4M | 7.5M | 11.2M | 9.6M | 7.5M |
| Operating expense total | 4.0M | 5.5M | 6.7M | 11.1M | 8.5M | 27.9M | 21.9M | 9.7M |
| EBIT | (3.9M) | (5.3M) | (6.1M) | (10.5M) | (8.6M) | (24.7M) | (17.4M) | (4.3M) |
| EBIT margin, % | -2797.8% | -1207.6% | -652.1% | -1162.5% | -452.5% | -157.7% | -35.4% | |
| Interest income | 1.8K | 152.6K | 379.5K | |||||
| Interest expense | 1.1M | 23.7K | 2.3K | 258.4K | ||||
| Net Income | (5.7M) | (5.3M) | (7.8M) | (10.9M) | (8.6M) | (24.7M) | (14.9M) | 158.0K |
| EPS | 0.1 |